Lower GI Bleeding
Conditions
Keywords
Discharge, lower gastrointestinal bleeding, Oakland score, SHA2PE score
Brief summary
The increasing incidence in lower gastrointestinal bleeding (LGIB) leads to a rise in hospital admission. Many LGBI are self-limiting thus the several scores to identify low risk patients suited to outpatient care have been described. We aim to compare two of this scores (Oakland score and SHA2PE score) in terms of performace to predict safe discharge from the emergency department.
Detailed description
The growing incidence of lower gastrointestinal bleeding (LGIB) is leading to a rise in hospital admissions even though most LGIB episodes are self-limiting. The Oakland and SHA2PE scores were designed to identify patients best suited to outpatient care. Our aim is to validate the SHA2PE score and compare both of these scores in terms of predictiveness of safe discharge. We conducted a retrospective observational study of LGIB patients admitted to our hospital between June 2014-June 2019. During this period, data from all LGIB episodes admitted from the ED were collected in an electronic anonymized database created specifically for this study. If any of the principal variables or critical information was missing, the patient was excluded from the study.
Interventions
There was no specific intervention, we only aimed to see if those admitted patients could have been safely dicharged from the emergency department.
Sponsors
Study design
Eligibility
Inclusion criteria
* All \> 18 year old patients, male and women, admitted to our hospital between June 2014 and June 2019 because of LGIB (lower gastrointestinal bleeding).
Exclusion criteria
* Patients in whom LGIB occurred while already admitted for an other cause. * Patients with LGIB transferred from another hospital due to comorbidities or severity of the gastrointestinal bleeding episode. * Patients with post-polypectomy LGIB (endoscopic polypectomy \<14 days before admission). * Patients with gastrointestinal bleeding of unknown origin after a complete study. * Patients who had undergone digestive tract surgery in the previous month. * Patients with an ostomy. * Patients with known colorectal cancer who had not undergone surgery.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safe Discharge | After 1 month of follow-up from the hospital discharge | Patients with lower gastrointestinal bleeding and absence of all the following: rebleeding, re-consulting for LGIB within 28 days after discharge, in-hospital mortality, requirement of red blood cell transfusion or endoscopic, radiological, or surgical haemostatic treatment. |
| Validation of SHA2PE score in our cohort | After 1 month of follow-up from the hospital discharge | We aim to validate this score in a southern Europe cohort and compare it to the Oakland score |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Performance of Oakland score in safe discharge | After 1 month of follow-up from the hospital discharge | We calculated the sensibility, specificity, positive and negative predictive values of the Oakland score in our patients cohort. |
| Performance of SHA2PE score in safe discharge | After 1 month of follow-up from the hospital discharge | We calculated the sensibility, specificity, positive and negative predictive values of the SHA2PE score in our patients cohort. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Demographic characterisctics of our cohort | After 1 month of follow-up from the hospital discharge | Description of the main characteristics of the patients admitted due to lower gastrointestinal bleeding |
Countries
Spain